Optimax Holdings Berhad, an investment holding company, engages in the provision of eye specialist services and related products in Malaysia. The company’s specialist centers offer a range of treatments relating to eye diseases, such as cataracts, glaucoma, conjunctivitis, age-related macular degeneration, diabetic retinopathy, retinal detachment, pterygium, keratoconus, dry eyes, and other eye diseases and disorders. It also provides services for treatment of myopia, amblyopia, and squint eyes for kids; eye examination, ortho-k specialist, and orthoptist services for kids; plastic surgery and aesthetic services; lasik surgery service; refractive surgery, consultation and dispensary, oculoplastic surgery, and eye examination services. In addition, the company markets food products; and retails pharmaceuticals, medical, orthopaedic goods, perfumery, cosmetic, and toilet articles. It serves international patients from Indonesia, the Philippines, Singapore, Thailand, Australia, China, Hong Kong, and Japan. Holdings Berhad was founded in 1995 and is headquartered in Kuala Lumpur, Malaysia.
Malaysian Market Performance
7D7 Days: 0.7%
3M3 Months: 0.6%
1Y1 Year: -3.8%
YTDYear to Date: -7.5%
The market has stayed flat over the 7 days. As for last year, the market is down 3.8%. Looking forward, earnings are forecast to grow by 8.7% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.